← Back to headlines
Grifols Reports 22% Profit Increase in Early Year
Grifols, the Catalan biopharmaceutical group, announced a 22% increase in profits to 73 million euros at the start of the year, driven by its biopharmaceutical division, with overall revenues growing 3% to 1.7 billion euros.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
